HealthQuill FDA
British pharmaceutical company, GSK Plc’s vaccine against the respiratory syncytial virus has shown positive data on its efficacy to treat older adults during a phase III stage trial.
Drugs Health Pharma

GSK’s RSV vaccine shows positive data on efficacy in older adults

HQ Team June 21, 2023: British pharmaceutical company, GSK Plc’s vaccine against the respiratory syncytial virus has shown positive data on its efficacy.

Read More
The USFDA has approved Pfizer Inc’s oral Talzenna drug in combination with Xtandi to treat advanced prostate cancer in adult patients, according to a statement.
Drugs Health Pharma

Pfizer gets FDA nod for combination drug to treat advanced prostate cancer

HQ Team June 21, 2023: The USFDA has approved Pfizer Inc’s oral Talzenna drug in combination with Xtandi to treat advanced prostate cancer.

Read More
Indian pharmaceutical company, Lupin Limited, has introduced its thiamine injection in the US market and has got FDA’s   ‘no action required’ classification for its domestic facility in the country’s south.
Drugs Health Pharma Uncategorized

India’s Lupin unveils thiamine injection in US, receives FDA’s NAR for Vizag unit

HQ Team June 20, 2023: Indian pharmaceutical company, Lupin Limited, has introduced its thiamine injection in the US market and has got FDA’s.

Read More
Valneva SE, a French vaccine maker, announced that its last-stage trials for its single-shot chikungunya registered a 98.9% vaccination success rate.
Drugs Medical Pharma

France’s Valneva says trial vaccine for chikungunya post 98.9% rate

HQ Team June 13, 2023: Valneva SE, a French vaccine maker, announced that its last-stage trials for its single-shot chikungunya registered a 98.9%.

Read More
An advisory committee of the USFDA has given a “favourable benefit-risk profile” for Sanofi and AstraZeneca’s experimental drug nirsevimab, meant to treat lower respiratory tract disease in newborns, according to a statement from the Paris-based firm.
Drugs Health Pharma

FDA’s advisory panel backs Sanofi, AstraZeneca’s investigational drug for newborns

HQ Team June 9, 2023: An advisory committee of the USFDA has given a “favourable benefit-risk profile” for Sanofi and AstraZeneca’s experimental drug.

Read More
The FDA cleared Opiant Pharmaceuticals’ nasal spray to treat opioid overdose in adult and paediatric patients under the regulator’s priority review designation.
Drugs Health Medical Pharma

Opiant’s nasal drug spray for opioid overdose gets FDA green light

HQ Team May 23, 2023: The FDA cleared Opiant Pharmaceuticals’ nasal spray to treat opioid overdose in adult and paediatric patients under the.

Read More
AbbVie Inc and Danish drugmaker, Genmab, announced they have got FDA’s approval for a therapy to treat blood cancer in adults who have undergone at least two prior treatments.
Drugs Health Medical Pharma

AbbVie, Genmab get FDA approval for blood cancer therapy

HQ Team May 20, 2023: AbbVie Inc and Danish drugmaker, Genmab, announced they have got FDA’s approval for a therapy to treat blood.

Read More
Astellas Pharma, a Japanese drugmaker, announced that the FDA has approved its oral drug Veozah for the treatment of hot flushes in menopausal women.
Drugs Health Pharma

Astellas drug to treat menopausal hot flashes gets FDA’s green light

HQ Team May 14, 2023: Astellas Pharma, a Japanese drugmaker, announced that the FDA has approved its oral drug Veozah for the treatment.

Read More
The FDA has warned consumers against the use of fast-act rheum and UA-Block capsules used to treat inflammation and joint pains as it contains substances that raise blood sugar, heart attacks, and stroke.
Drugs Health Medical Pharma

FDA warns against use of Fast-act and UA-Block capsules to treat rheumatism

HQ Team May 11, 2023: The FDA has warned consumers against using fast-act rheum and UA-Block capsules to treat inflammation and joint pains.

Read More
The USFDA has warned healthcare providers and consumers from using SD Biosensor Inc. pilot COVID-19 at-home tests due to bacterial contamination.
Drugs Health Medical Pharma

FDA issues warning on SD Biosensor’s at-home COVID-19 test

HQ Team May 5, 2023: The USFDA has warned healthcare providers and consumers from using SD Biosensor Inc. pilot COVID-19 at-home tests due.

Read More